Literature DB >> 17383517

Cancer stem cells: a new paradigm for understanding tumor progression and therapeutic resistance.

Emina H Huang1, David G Heidt, Chen-Wei Li, Diane M Simeone.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17383517     DOI： 10.1016/j.surg.2006.12.015

Source DB:  PubMed          Journal:  Surgery        ISSN： 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  28 in total

1.  [PET-CT studies of metastasizing cancer of the colon and rectum. Variability of tumor aggressiveness as a micro-evolutionary process of cancer stem cells with predetermined prognosis].

Authors:  F Stelzner; D von Mallek; J Ruhlmann; H J Biersack
Journal:  Chirurg       Date:  2009-07       Impact factor: 0.955

2.  Effect of RNA interference-related HiWi gene expression on the proliferation and apoptosis of lung cancer stem cells.

Authors:  Dong Liang; Zehui Fang; Min Dong; Chao Liang; Chonghao Xing; Juan Zhao; Yiju Yang
Journal:  Oncol Lett       Date:  2012-04-11       Impact factor: 2.967

3.  Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.

Authors:  Ilona Kryczek; Suling Liu; Michael Roh; Linhua Vatan; Wojciech Szeliga; Shuang Wei; Mousumi Banerjee; Yujun Mao; Jan Kotarski; Max S Wicha; Rebecca Liu; Weiping Zou
Journal:  Int J Cancer       Date:  2011-04-08       Impact factor: 7.396

Review 4.  Tumour-associated antigens: considerations for their use in tumour immunotherapy.

Authors:  Adam J Linley; Murrium Ahmad; Robert C Rees
Journal:  Int J Hematol       Date:  2011-03-01       Impact factor: 2.490

5.  Comparison of RECIST, EORTC criteria and PERCIST for evaluation of early response to chemotherapy in patients with non-small-cell lung cancer.

Authors:  Jingjie Shang; Xueying Ling; Linyue Zhang; Yongjin Tang; Zeyu Xiao; Yong Cheng; Bin Guo; Jian Gong; Li Huang; Hao Xu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-05-28       Impact factor: 9.236

6.  B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models.

Authors:  Benjamin B Kasten; Rebecca C Arend; Ashwini A Katre; Harrison Kim; Jinda Fan; Soldano Ferrone; Kurt R Zinn; Donald J Buchsbaum
Journal:  Nucl Med Biol       Date:  2017-01-10       Impact factor: 2.408

Review 7.  Ovarian cancer stem cells and inflammation.

Authors:  Gil Mor; Gang Yin; Ilana Chefetz; Yang Yang; Ayesha Alvero
Journal:  Cancer Biol Ther       Date:  2011-04-15       Impact factor: 4.742

8.  Drug-eluting microarrays to identify effective chemotherapeutic combinations targeting patient-derived cancer stem cells.

Authors:  Matthew R Carstens; Robert C Fisher; Abhinav P Acharya; Elizabeth A Butterworth; Edward Scott; Emina H Huang; Benjamin G Keselowsky
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

9.  Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study.

Authors:  F Jeroen Vogelaar; Wilma E Mesker; Arjen M Rijken; Gaby W van Pelt; Antonia M van Leeuwen; Hans J Tanke; Rob A Tollenaar; Gerrit J Liefers
Journal:  BMC Cancer       Date:  2010-04-20       Impact factor: 4.430

10.  Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells.

Authors:  Lilly Y W Bourguignon; Karine Peyrollier; Weiliang Xia; Eli Gilad
Journal:  J Biol Chem       Date:  2008-04-25       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.